CardioGenics Holdings (CardioGenics Holdings) EBITDA Margin % : 0.00% (As of Jan. 2016)

CardioGenics Holdings EBITDA Margin % Chart

CardioGenics Holdings Annual Data
	Trend	Jul06	Jul07	Jul08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15
EBITDA Margin %		Get a 7-Day Free Trial					-61,888.89	-127,000.00	-	-	-

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
EBITDA Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CardioGenics Holdings's EBITDA Margin %

For the Diagnostics & Research subindustry, CardioGenics Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's EBITDA Margin % falls into.

CardioGenics Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CardioGenics Holdings's EBITDA Margin % for the fiscal year that ended in Oct. 2015 is calculated as

CardioGenics Holdings's EBITDA Margin % for the quarter that ended in Jan. 2016 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CardioGenics Holdings  (OTCPK:CGNH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

CardioGenics Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description